Related Experiment Video

Updated: Jan 28, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.4K

Correction to: Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors:

Helmut Schöllnberger1,2, Markus Eidemüller3, Harry M Cullings4

  • 1Helmholtz Zentrum München, Department of Radiation Sciences, Institute of Radiation Protection, Ingolstädter Landstrasse 1, 85764, Neuherberg, Germany. hschoellnberger@bfs.de.

Radiation and Environmental Biophysics
|February 26, 2019
PubMed

Insights

This study analyzed mortality risks for cerebrovascular and heart diseases in atomic bomb survivors. Findings reveal increased risks associated with radiation exposure, informing public health strategies.

Area of Science:

  • Epidemiology
  • Radiation Oncology
  • Cardiovascular Disease Research

Context:

  • Investigates long-term health effects of atomic bomb radiation exposure.
  • Utilizes mortality data from atomic bomb survivors spanning several decades.
  • Focuses on specific non-cancerous diseases: cerebrovascular and heart conditions.

Purpose:

  • To establish dose-response relationships between radiation exposure and mortality from cerebrovascular and heart diseases.
  • To quantify the excess risk of these diseases attributable to ionizing radiation.
  • To provide updated risk estimates for radiation protection and health policy.

Summary:

  • Analyzed mortality data from 1950-2003 for atomic bomb survivors.
  • Examined dose-response relationships for cerebrovascular and heart disease mortality.
  • Found statistically significant associations between radiation dose and increased mortality for these conditions.

Impact:

  • Informs understanding of radiation's impact on cardiovascular and cerebrovascular health.
  • Contributes to evidence-based guidelines for radiation protection.
  • Highlights the importance of long-term health surveillance for exposed populations.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.2K
Whole Body Vibration Methods with Survivors of Polio04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

9.2K

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.0K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.7K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
510
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
270